News

Simply Good Foods Company 2025 Financial Results and Future Plans

Simply Good Foods Company 2025 Financial Results and Future Plans

Overview of Simply Good Foods Company

Simply Good Foods Company (NASDAQ: SMPL) is a prominent player in the nutritional snacking sector. This dynamic company reports its financial results for the fourth quarter and full year, positioning itself as a leader amid evolving consumer behaviors.

Fourth Quarter Financial Highlights

In the recent fourth quarter, the company reported net sales of $369.0 million, slightly lower than $375.7 million from the previous year. The shift reflects the adjustments made due to the acquisition of Only What You Need, Inc. (OWYN), which has now been integrated into their overall business strategy. This quarter showed a net loss of $12.4 million compared to a net income of $29.3 million during the same period last year, emphasizing the volatility in the current market environment.

Key Metrics from the Fourth Quarter

The highlights of the fourth quarter include:

  • Net loss of $12.4 million against a net income of $29.3 million.
  • Earnings per diluted share at a loss of $0.12 compared to earnings of $0.29 in the prior year.
  • Adjusted Diluted Earnings Per Share (EPS) reduced to $0.46 from $0.50.
  • Adjusted EBITDA totaled $66.2 million, a decline from $77.5 million.

Full Fiscal Year Performance

For the fiscal year 2025, Simply Good Foods achieved remarkable growth, with total net sales reaching $1,450.9 million, compared to $1,331.3 million in the prior fiscal year. This equates to a 9% increase, demonstrating resilience as they navigate through various challenges.

Year-End Results

Further breakdowns reveal:

  • Adjusted diluted EPS increased to $1.92 from $1.83.
  • Gross profit rose to $525.7 million despite inflationary pressures, showcasing operational efficiency.
  • Total operating expenses were $368.9 million, reflecting strategic investments.

Looking Ahead: Fiscal Year 2026 Outlook

The outlook for fiscal year 2026 projects net sales to fluctuate between a decrease of 2% and an increase of 2% year-over-year. The company anticipates adjustments in gross margins while continuing to focus on the innovation and market presence of their brands.

Management’s Vision for Future Growth

President and CEO Geoff Tanner highlighted the company’s strategy to overcome market challenges, emphasizing sound management and innovative marketing to enhance product performance. The approach includes leveraging strong cash flow for growth, striving for heightened operational excellence across their brand portfolio.

Strategic Financial Initiatives

In a move to strengthen shareholder value and financial positioning, the company's Board of Directors approved a $150 million increase to its stock repurchase program. This strategic decision exhibits a commitment to returning capital to shareholders while balancing growth initiatives.

Balance Sheet Insights

At the end of fiscal year 2025, Simply Good Foods reported cash of $98.5 million alongside a manageable debt level, setting a solid foundation for its upcoming fiscal activities.

Frequently Asked Questions

What were the main financial results for Simply Good Foods in Q4 2025?

Simply Good Foods reported net sales of $369.0 million, alongside a net loss of $12.4 million against net income of $29.3 million in Q4 2024.

How did the fiscal year 2025 perform overall compared to the previous year?

The company achieved net sales of $1,450.9 million, reflecting a 9% growth from $1,331.3 million in the prior year.

What is the projection for fiscal year 2026?

Simply Good Foods anticipates minimal growth in net sales, projecting a range between -2% and +2% year-over-year.

What strategic initiatives were highlighted by the company’s leadership?

The management outlined their vision of enhancing innovation, marketing effectiveness, and exploring advantageous growth opportunities in the snack sector.

How is the company managing stockholder returns?

The Board approved a $150 million increase in the stock repurchase program, signaling their commitment to bolster shareholder value.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 85

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 207

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 79

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 378

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading

Top 5 Most Recently Viewed Articles

Trex Company Investigated for Securities Fraud: What Investors Need to Know

Updated Category News Views 181

Trex Company, Inc. Under Scrutiny for Securities Violations Trex Company, Inc. (NYSE: TREX) is currently facing an investigation regarding potential violations of federal securities laws. This inquiry is being conducted by the Law Offices of Howard G. Smith. The investigation stems from the company's recent financial disclosures, which raised concerns among investors....

Continue Reading
IRONMAN and Experience Oman Join Forces for Global Sports

Updated Category News Views 297

IRONMAN Partners with Experience Oman for a Dynamic Future The recent alliance between IRONMAN and Experience Oman marks a groundbreaking development in the realm of sports tourism. This partnership sets the stage for the prestigious IRONMAN 70.3 World Championship to take place in Oman, specifically in its capital of Muscat. Through this collaboration, Experience Oman...

Continue Reading
Exploring Quantica Tech's Innovative Quantic Bitcoin Initiative

Updated Category News Views 182

Introducing Quantic Bitcoin by Quantica Tech Quantica Tech, renowned for its innovations in quantum computing for blockchain, has embarked on an exciting project: Quantic Bitcoin (BTCQ). This initiative signifies a major leap towards integrating quantum computing capabilities into the decentralized finance landscape. With the development of a unique quantum...

Continue Reading
Exploring Integrity in NYC Real Estate Media Reporting

Updated Category News Views 227

Assessing the Reliability of Bisnow's NYC Real Estate Reporting In the fast-paced world of New York City's real estate market, the accuracy of information plays a crucial role for various stakeholders, including investors, lenders, and policy-makers. These groups rely heavily on precise reporting to navigate the complex and often unpredictable regulatory landscape....

Continue Reading
Citi Analysts Recommend Buying Microsoft After Share Pullback

Updated Category News Views 70

Citi Analysts Recommend Buying Microsoft After Share Pullback Recent insights from analysts at Citi suggest that investors should consider purchasing Microsoft (NASDAQ: MSFT) shares following a notable price drop. They believe this presents an opportunity, highlighting potential upside in the coming quarters for the tech giant. Understanding Microsoft’s Current...

Continue Reading